Structure

Physi-Chem Properties

Molecular Weight:  610.19
Volume:  569.38
LogP:  0.187
LogD:  -0.149
LogS:  -2.066
# Rotatable Bonds:  11
TPSA:  245.29
# H-Bond Aceptor:  15
# H-Bond Donor:  9
# Rings:  4
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.085
Synthetic Accessibility Score:  4.695
Fsp3:  0.464
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.56
MDCK Permeability:  1.641145172470715e-05
Pgp-inhibitor:  0.003
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.983
20% Bioavailability (F20%):  0.967
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.103
Plasma Protein Binding (PPB):  95.1359634399414%
Volume Distribution (VD):  0.218
Pgp-substrate:  7.215146064758301%

ADMET: Metabolism

CYP1A2-inhibitor:  0.062
CYP1A2-substrate:  0.017
CYP2C19-inhibitor:  0.076
CYP2C19-substrate:  0.05
CYP2C9-inhibitor:  0.115
CYP2C9-substrate:  0.16
CYP2D6-inhibitor:  0.032
CYP2D6-substrate:  0.146
CYP3A4-inhibitor:  0.022
CYP3A4-substrate:  0.016

ADMET: Excretion

Clearance (CL):  1.14
Half-life (T1/2):  0.83

ADMET: Toxicity

hERG Blockers:  0.247
Human Hepatotoxicity (H-HT):  0.119
Drug-inuced Liver Injury (DILI):  0.331
AMES Toxicity:  0.596
Rat Oral Acute Toxicity:  0.135
Maximum Recommended Daily Dose:  0.014
Skin Sensitization:  0.977
Carcinogencity:  0.05
Eye Corrosion:  0.003
Eye Irritation:  0.164
Respiratory Toxicity:  0.022

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC260425

Natural Product ID:  NPC260425
Common Name*:   Calceolarioside C
IUPAC Name:   [(2R,3S,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-4,5-dihydroxy-2-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  GNDDBOHLMOANGU-TYGLCWKWSA-N
Standard InCHI:  InChI=1S/C28H34O15/c29-15-4-1-13(9-17(15)31)3-6-21(34)43-26-20(12-41-27-24(37)22(35)19(33)11-40-27)42-28(25(38)23(26)36)39-8-7-14-2-5-16(30)18(32)10-14/h1-6,9-10,19-20,22-33,35-38H,7-8,11-12H2/b6-3+/t19-,20-,22+,23-,24-,25-,26-,27+,28-/m1/s1
SMILES:  c1cc(c(cc1/C=C/C(=O)O[C@@H]1[C@@H](CO[C@H]2[C@@H]([C@H]([C@@H](CO2)O)O)O)O[C@H]([C@@H]([C@H]1O)O)OCCc1ccc(c(c1)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3632940
PubChem CID:   45360240
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0000059] Coumaric acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19805 Forsythia viridissima Species Oleaceae Eukaryota n.a. flower n.a. PMID[15481244]
NPO21387 Forsythia suspensa Species Oleaceae Eukaryota n.a. n.a. n.a. PMID[17156960]
NPO21387 Forsythia suspensa Species Oleaceae Eukaryota n.a. n.a. n.a. PMID[26422318]
NPO21387 Forsythia suspensa Species Oleaceae Eukaryota Fruits n.a. n.a. PMID[28218000]
NPO19805 Forsythia viridissima Species Oleaceae Eukaryota Roots n.a. n.a. PMID[30676026]
NPO19805 Forsythia viridissima Species Oleaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21387 Forsythia suspensa Species Oleaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21387 Forsythia suspensa Species Oleaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO19805 Forsythia viridissima Species Oleaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO19805 Forsythia viridissima Species Oleaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO21387 Forsythia suspensa Species Oleaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO21387 Forsythia suspensa Species Oleaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT681 Cell Line PC-12 Rattus norvegicus Activity = 56.2 % PMID[564180]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC260425 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9924 High Similarity NPC89105
0.9924 High Similarity NPC476383
0.9924 High Similarity NPC81515
0.9924 High Similarity NPC197316
0.9924 High Similarity NPC68092
0.9924 High Similarity NPC205195
0.9924 High Similarity NPC64141
0.9924 High Similarity NPC472350
0.9847 High Similarity NPC78363
0.9774 High Similarity NPC476385
0.9774 High Similarity NPC476377
0.9774 High Similarity NPC134405
0.9774 High Similarity NPC47471
0.9769 High Similarity NPC287597
0.9769 High Similarity NPC34293
0.9769 High Similarity NPC886
0.9701 High Similarity NPC265648
0.9701 High Similarity NPC222433
0.9699 High Similarity NPC475530
0.9699 High Similarity NPC473799
0.963 High Similarity NPC476380
0.963 High Similarity NPC269141
0.963 High Similarity NPC205864
0.963 High Similarity NPC76406
0.963 High Similarity NPC119537
0.963 High Similarity NPC175214
0.963 High Similarity NPC476381
0.963 High Similarity NPC247032
0.963 High Similarity NPC112
0.963 High Similarity NPC476397
0.963 High Similarity NPC476384
0.963 High Similarity NPC264632
0.963 High Similarity NPC105005
0.963 High Similarity NPC96795
0.963 High Similarity NPC298257
0.963 High Similarity NPC476378
0.963 High Similarity NPC476375
0.9624 High Similarity NPC321638
0.9624 High Similarity NPC171134
0.9624 High Similarity NPC328273
0.9624 High Similarity NPC321184
0.9559 High Similarity NPC296954
0.9559 High Similarity NPC300894
0.9559 High Similarity NPC196063
0.9559 High Similarity NPC141455
0.9559 High Similarity NPC64195
0.9549 High Similarity NPC476376
0.9545 High Similarity NPC476870
0.9489 High Similarity NPC34927
0.9489 High Similarity NPC34587
0.9489 High Similarity NPC100998
0.9489 High Similarity NPC252292
0.9489 High Similarity NPC476382
0.9466 High Similarity NPC473285
0.942 High Similarity NPC229505
0.9389 High Similarity NPC235294
0.9389 High Similarity NPC46137
0.9385 High Similarity NPC477293
0.9385 High Similarity NPC229784
0.9385 High Similarity NPC477294
0.9353 High Similarity NPC232992
0.9343 High Similarity NPC40305
0.9318 High Similarity NPC254275
0.9308 High Similarity NPC232880
0.9275 High Similarity NPC476867
0.927 High Similarity NPC140502
0.9242 High Similarity NPC219677
0.9242 High Similarity NPC246869
0.9242 High Similarity NPC225384
0.9242 High Similarity NPC138777
0.9237 High Similarity NPC184092
0.9231 High Similarity NPC476873
0.9231 High Similarity NPC288416
0.922 High Similarity NPC476398
0.922 High Similarity NPC259347
0.922 High Similarity NPC94871
0.922 High Similarity NPC471062
0.922 High Similarity NPC306890
0.922 High Similarity NPC476386
0.922 High Similarity NPC470933
0.922 High Similarity NPC473427
0.9209 High Similarity NPC476866
0.9209 High Similarity NPC476868
0.9209 High Similarity NPC476869
0.9209 High Similarity NPC476864
0.9197 High Similarity NPC186406
0.9179 High Similarity NPC471883
0.9173 High Similarity NPC473924
0.9155 High Similarity NPC257970
0.9155 High Similarity NPC188393
0.9155 High Similarity NPC470927
0.9155 High Similarity NPC470934
0.9143 High Similarity NPC476865
0.9111 High Similarity NPC263829
0.9104 High Similarity NPC254398
0.9098 High Similarity NPC478255
0.9084 High Similarity NPC79715
0.9084 High Similarity NPC108659
0.9084 High Similarity NPC264900
0.9084 High Similarity NPC231607
0.9077 High Similarity NPC83218
0.9077 High Similarity NPC126991
0.9065 High Similarity NPC478239
0.9028 High Similarity NPC106818
0.9015 High Similarity NPC225307
0.9014 High Similarity NPC28776
0.9014 High Similarity NPC473138
0.9008 High Similarity NPC471157
0.9008 High Similarity NPC94179
0.9 High Similarity NPC110063
0.9 High Similarity NPC232228
0.9 High Similarity NPC292443
0.8993 High Similarity NPC157816
0.8993 High Similarity NPC296643
0.8986 High Similarity NPC202700
0.8971 High Similarity NPC123988
0.8966 High Similarity NPC471874
0.8966 High Similarity NPC87403
0.8951 High Similarity NPC106138
0.8939 High Similarity NPC106677
0.8936 High Similarity NPC262182
0.8936 High Similarity NPC216819
0.8936 High Similarity NPC83743
0.8936 High Similarity NPC287615
0.8905 High Similarity NPC157554
0.8905 High Similarity NPC470572
0.8897 High Similarity NPC478268
0.8889 High Similarity NPC476871
0.8881 High Similarity NPC80732
0.8881 High Similarity NPC201148
0.8881 High Similarity NPC3460
0.8881 High Similarity NPC199311
0.8881 High Similarity NPC192763
0.8881 High Similarity NPC215095
0.8881 High Similarity NPC261122
0.8881 High Similarity NPC28651
0.8881 High Similarity NPC23677
0.8881 High Similarity NPC210611
0.8881 High Similarity NPC300262
0.8873 High Similarity NPC199928
0.8872 High Similarity NPC148982
0.8849 High Similarity NPC106944
0.8846 High Similarity NPC52097
0.8841 High Similarity NPC302583
0.8841 High Similarity NPC310252
0.8841 High Similarity NPC100558
0.8841 High Similarity NPC84789
0.8824 High Similarity NPC28637
0.8819 High Similarity NPC478242
0.8777 High Similarity NPC220942
0.8777 High Similarity NPC226005
0.8777 High Similarity NPC100389
0.8769 High Similarity NPC266045
0.8769 High Similarity NPC147654
0.8769 High Similarity NPC11724
0.8768 High Similarity NPC177035
0.8768 High Similarity NPC186418
0.8768 High Similarity NPC199459
0.8768 High Similarity NPC471664
0.8768 High Similarity NPC52277
0.8768 High Similarity NPC471665
0.8759 High Similarity NPC35731
0.8759 High Similarity NPC135127
0.8722 High Similarity NPC252114
0.8705 High Similarity NPC126206
0.8705 High Similarity NPC470413
0.8705 High Similarity NPC138738
0.8699 High Similarity NPC125823
0.8699 High Similarity NPC85192
0.8699 High Similarity NPC140151
0.8699 High Similarity NPC143480
0.8699 High Similarity NPC7145
0.8692 High Similarity NPC476872
0.869 High Similarity NPC90896
0.869 High Similarity NPC283839
0.8662 High Similarity NPC204644
0.8662 High Similarity NPC113680
0.8662 High Similarity NPC278961
0.8658 High Similarity NPC11411
0.8657 High Similarity NPC156692
0.8657 High Similarity NPC45224
0.8657 High Similarity NPC173150
0.8657 High Similarity NPC471881
0.8657 High Similarity NPC35288
0.8657 High Similarity NPC471882
0.8647 High Similarity NPC90318
0.8639 High Similarity NPC289967
0.8639 High Similarity NPC53587
0.8639 High Similarity NPC472611
0.8639 High Similarity NPC472612
0.8639 High Similarity NPC176186
0.8639 High Similarity NPC169404
0.8633 High Similarity NPC37468
0.8633 High Similarity NPC154485
0.8633 High Similarity NPC471345
0.8633 High Similarity NPC471872
0.863 High Similarity NPC12006
0.863 High Similarity NPC69367
0.8621 High Similarity NPC116229
0.8621 High Similarity NPC478237

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC260425 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9924 High Similarity NPD7266 Discontinued
0.8311 Intermediate Similarity NPD1653 Approved
0.8276 Intermediate Similarity NPD6190 Approved
0.7888 Intermediate Similarity NPD7054 Approved
0.7853 Intermediate Similarity NPD7685 Pre-registration
0.784 Intermediate Similarity NPD7074 Phase 3
0.784 Intermediate Similarity NPD7472 Approved
0.7826 Intermediate Similarity NPD7228 Approved
0.7746 Intermediate Similarity NPD3027 Phase 3
0.7744 Intermediate Similarity NPD7251 Discontinued
0.7708 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD1613 Approved
0.7707 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD6797 Phase 2
0.7607 Intermediate Similarity NPD3818 Discontinued
0.759 Intermediate Similarity NPD7808 Phase 3
0.758 Intermediate Similarity NPD8455 Phase 2
0.7566 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6234 Discontinued
0.7483 Intermediate Similarity NPD8166 Discontinued
0.7456 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7431 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD1091 Approved
0.7417 Intermediate Similarity NPD6674 Discontinued
0.7415 Intermediate Similarity NPD230 Phase 1
0.7405 Intermediate Similarity NPD37 Approved
0.7375 Intermediate Similarity NPD4965 Approved
0.7375 Intermediate Similarity NPD4966 Approved
0.7375 Intermediate Similarity NPD4967 Phase 2
0.7365 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7361 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD8313 Approved
0.7337 Intermediate Similarity NPD8312 Approved
0.7321 Intermediate Similarity NPD7240 Approved
0.7315 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD6166 Phase 2
0.7273 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD3021 Approved
0.7239 Intermediate Similarity NPD3022 Approved
0.7219 Intermediate Similarity NPD6559 Discontinued
0.7197 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD1934 Approved
0.7183 Intermediate Similarity NPD3705 Approved
0.7171 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD4380 Phase 2
0.7143 Intermediate Similarity NPD4628 Phase 3
0.7143 Intermediate Similarity NPD1465 Phase 2
0.7143 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD3455 Phase 2
0.7092 Intermediate Similarity NPD1357 Approved
0.7091 Intermediate Similarity NPD7199 Phase 2
0.7086 Intermediate Similarity NPD7097 Phase 1
0.7067 Intermediate Similarity NPD4340 Discontinued
0.7045 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7042 Intermediate Similarity NPD5125 Phase 3
0.7042 Intermediate Similarity NPD5126 Approved
0.7041 Intermediate Similarity NPD5844 Phase 1
0.7012 Intermediate Similarity NPD7075 Discontinued
0.7007 Intermediate Similarity NPD969 Suspended
0.7007 Intermediate Similarity NPD2861 Phase 2
0.7007 Intermediate Similarity NPD228 Approved
0.7 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4060 Phase 1
0.6994 Remote Similarity NPD5402 Approved
0.6994 Remote Similarity NPD3817 Phase 2
0.6988 Remote Similarity NPD8127 Discontinued
0.698 Remote Similarity NPD3764 Approved
0.6968 Remote Similarity NPD1652 Phase 2
0.695 Remote Similarity NPD5536 Phase 2
0.6943 Remote Similarity NPD5058 Phase 3
0.694 Remote Similarity NPD7680 Approved
0.6933 Remote Similarity NPD2977 Approved
0.6933 Remote Similarity NPD2801 Approved
0.6933 Remote Similarity NPD2978 Approved
0.6933 Remote Similarity NPD6233 Phase 2
0.6913 Remote Similarity NPD7095 Approved
0.6908 Remote Similarity NPD5314 Approved
0.6905 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6901 Remote Similarity NPD9545 Approved
0.6899 Remote Similarity NPD1511 Approved
0.6897 Remote Similarity NPD9269 Phase 2
0.6887 Remote Similarity NPD3062 Approved
0.6887 Remote Similarity NPD3059 Approved
0.6887 Remote Similarity NPD3061 Approved
0.6882 Remote Similarity NPD3751 Discontinued
0.6875 Remote Similarity NPD5403 Approved
0.6855 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6848 Remote Similarity NPD3882 Suspended
0.6846 Remote Similarity NPD4908 Phase 1
0.6842 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6842 Remote Similarity NPD5124 Phase 1
0.6838 Remote Similarity NPD1358 Approved
0.6829 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6813 Remote Similarity NPD1512 Approved
0.6806 Remote Similarity NPD9381 Approved
0.6806 Remote Similarity NPD9384 Approved
0.6797 Remote Similarity NPD6653 Approved
0.679 Remote Similarity NPD7458 Discontinued
0.6786 Remote Similarity NPD5283 Phase 1
0.6779 Remote Similarity NPD5736 Approved
0.6776 Remote Similarity NPD3620 Phase 2
0.6776 Remote Similarity NPD943 Approved
0.6776 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6774 Remote Similarity NPD9570 Approved
0.6774 Remote Similarity NPD2935 Discontinued
0.6768 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6759 Remote Similarity NPD3496 Discontinued
0.6757 Remote Similarity NPD3094 Phase 2
0.6755 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6755 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6755 Remote Similarity NPD6798 Discontinued
0.6753 Remote Similarity NPD4538 Approved
0.6753 Remote Similarity NPD4536 Approved
0.6753 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6752 Remote Similarity NPD5698 Clinical (unspecified phase)
0.675 Remote Similarity NPD7004 Clinical (unspecified phase)
0.675 Remote Similarity NPD5401 Approved
0.6746 Remote Similarity NPD6232 Discontinued
0.6746 Remote Similarity NPD3787 Discontinued
0.6735 Remote Similarity NPD2983 Phase 2
0.6735 Remote Similarity NPD2982 Phase 2
0.6732 Remote Similarity NPD6355 Discontinued
0.6732 Remote Similarity NPD1933 Approved
0.6731 Remote Similarity NPD5763 Approved
0.6731 Remote Similarity NPD5762 Approved
0.6728 Remote Similarity NPD3687 Approved
0.6728 Remote Similarity NPD3686 Approved
0.6727 Remote Similarity NPD7819 Suspended
0.6725 Remote Similarity NPD7473 Discontinued
0.6723 Remote Similarity NPD8150 Discontinued
0.672 Remote Similarity NPD8319 Approved
0.672 Remote Similarity NPD8320 Phase 1
0.6714 Remote Similarity NPD7843 Approved
0.6712 Remote Similarity NPD1610 Phase 2
0.6712 Remote Similarity NPD422 Phase 1
0.671 Remote Similarity NPD5588 Approved
0.671 Remote Similarity NPD5960 Phase 3
0.6709 Remote Similarity NPD3750 Approved
0.6708 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6707 Remote Similarity NPD6385 Approved
0.6707 Remote Similarity NPD6386 Approved
0.6705 Remote Similarity NPD7090 Clinical (unspecified phase)
0.669 Remote Similarity NPD7157 Approved
0.6689 Remote Similarity NPD3225 Approved
0.6686 Remote Similarity NPD7549 Discontinued
0.6685 Remote Similarity NPD6843 Phase 3
0.6685 Remote Similarity NPD6842 Approved
0.6685 Remote Similarity NPD6841 Approved
0.6667 Remote Similarity NPD2981 Phase 2
0.6667 Remote Similarity NPD7435 Discontinued
0.6667 Remote Similarity NPD826 Approved
0.6667 Remote Similarity NPD6801 Discontinued
0.6667 Remote Similarity NPD1548 Phase 1
0.6667 Remote Similarity NPD825 Approved
0.6667 Remote Similarity NPD3018 Phase 2
0.6667 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7699 Phase 2
0.6667 Remote Similarity NPD9494 Approved
0.6667 Remote Similarity NPD8151 Discontinued
0.6667 Remote Similarity NPD7700 Phase 2
0.6667 Remote Similarity NPD1558 Phase 1
0.6646 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6646 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6646 Remote Similarity NPD3060 Approved
0.6646 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6642 Remote Similarity NPD1242 Phase 1
0.6642 Remote Similarity NPD3134 Approved
0.6641 Remote Similarity NPD2934 Approved
0.6641 Remote Similarity NPD2933 Approved
0.6629 Remote Similarity NPD7039 Approved
0.6629 Remote Similarity NPD7038 Approved
0.6627 Remote Similarity NPD5494 Approved
0.6622 Remote Similarity NPD9622 Approved
0.6621 Remote Similarity NPD9268 Approved
0.6607 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6606 Remote Similarity NPD7411 Suspended
0.6604 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6604 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6604 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6604 Remote Similarity NPD4110 Phase 3
0.6603 Remote Similarity NPD7033 Discontinued
0.6603 Remote Similarity NPD4108 Discontinued
0.6601 Remote Similarity NPD6663 Approved
0.6601 Remote Similarity NPD4062 Phase 3
0.6599 Remote Similarity NPD3092 Approved
0.6596 Remote Similarity NPD5535 Approved
0.6593 Remote Similarity NPD6534 Approved
0.6593 Remote Similarity NPD6535 Approved
0.6591 Remote Similarity NPD2859 Approved
0.6591 Remote Similarity NPD2860 Approved
0.6585 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6584 Remote Similarity NPD4357 Discontinued
0.6584 Remote Similarity NPD6799 Approved
0.6582 Remote Similarity NPD1549 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data